Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

32 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Prevalence of Progression Independent of Relapse Activity and Relapse-Associated Worsening in Patients With AQP4-IgG-Positive NMOSD.
Siriratnam P, Huda S, Van Der Walt A, Sanfilippo PG, Sharmin S, Foong YC, Yeh WZ, Zhu C, Khoury SJ, Csepany T, Willekens B, Etemadifar M, Ozakbas S, Nytrova P, Altintas A, Al-Asmi A, Ramo-Tello CM, Laureys G, Patti F, Horakova D, Foschi M, Boz C, Mccombe PA, Turkoglu R, Lechner-Scott J, Roos I, Kalincik T, Jokubaitis VG, Butzkueven H, Monif M; for MSBase. Siriratnam P, et al. Among authors: nytrova p. Neurology. 2024 Dec 24;103(12):e209940. doi: 10.1212/WNL.0000000000209940. Epub 2024 Nov 19. Neurology. 2024. PMID: 39561307
Predictors of relapse risk and treatment response in AQP4-IgG positive and seronegative NMOSD: A multicentre study.
Siriratnam P, Sanfilippo P, van der Walt A, Sharmin S, Foong YC, Yeh WZ, Zhu C, Khoury SJ, Csepany T, Willekens B, Etemadifar M, Ozakbas S, Nytrova P, Altintas A, Al-Asmi A, Yamout B, Laureys G, Patti F, Simo M, Surcinelli A, Foschi M, McCombe PA, Alroughani R, Sánchez-Menoyo JL, Turkoglu R, Soysal A, Lechner Scott J, Kalincik T, Butzkueven H, Jokubaitis V, Huda S, Monif M; MSBASE study group. Siriratnam P, et al. Among authors: nytrova p. J Neurol Neurosurg Psychiatry. 2024 Sep 4:jnnp-2024-334090. doi: 10.1136/jnnp-2024-334090. Online ahead of print. J Neurol Neurosurg Psychiatry. 2024. PMID: 39231582
Patients with multiple sclerosis who develop immunogenicity to interferon-beta have distinct transcriptomic and proteomic signatures prior to treatment which are associated with disease severity.
Coelewij L, Adriani M, Dönnes P, Waddington KE, Ciurtin C, Havrdova EK; ABIRISK Consortium; Farrell R, Nytrova P, Pineda-Torra I, Jury EC. Coelewij L, et al. Among authors: nytrova p. Clin Immunol. 2024 Oct;267:110339. doi: 10.1016/j.clim.2024.110339. Epub 2024 Aug 11. Clin Immunol. 2024. PMID: 39137826 Free article.
Abnormal Cerebrospinal Fluid Cytology in Functional Movement Disorders.
Serranová T, Slovák M, Forejtová Z, Sieger T, Dušek P, Srpová B, Mrázová K, Růžička E, Šonka K, Espay AJ, Nytrová P. Serranová T, et al. Among authors: nytrova p. Psychosom Med. 2024 Jul-Aug 01;86(6):555-560. doi: 10.1097/PSY.0000000000001307. Epub 2024 Mar 25. Psychosom Med. 2024. PMID: 38573035
Tract-wise microstructural analysis informs on current and future disability in early multiple sclerosis.
Ravano V, Piredda GF, Krasensky J, Andelova M, Uher T, Srpova B, Havrdova EK, Vodehnalova K, Horakova D, Nytrova P, Disselhorst JA, Hilbert T, Maréchal B, Thiran JP, Kober T, Richiardi J, Vaneckova M. Ravano V, et al. Among authors: nytrova p. J Neurol. 2024 Feb;271(2):631-641. doi: 10.1007/s00415-023-12023-3. Epub 2023 Oct 11. J Neurol. 2024. PMID: 37819462 Free PMC article.
32 results